SIMILAR PATTERNS OF AMINO ACIDS FOR 2R5Q_D_1UND900

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism
Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1bou 4,5-DIOXYGENASE BETA
CHAIN


(Sphingomonas
paucimobilis)
PF02900
(LigB)
5 LEU B 133
ILE B 277
GLY B   7
PRO B  51
ILE B 136
None
1.05A 2r5qC-1bouB:
undetectable
2r5qC-1bouB:
14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1c0n PROTEIN (CSDB
PROTEIN)


(Escherichia
coli)
PF00266
(Aminotran_5)
5 LEU A 198
GLY A 234
ILE A 235
VAL A 101
ILE A  98
None
1.13A 2r5qC-1c0nA:
undetectable
2r5qC-1c0nA:
13.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1dby CHLOROPLAST
THIOREDOXIN M CH2


(Chlamydomonas
reinhardtii)
PF00085
(Thioredoxin)
5 LEU A  57
ILE A  37
GLY A  91
ILE A  90
VAL A  24
None
0.94A 2r5qC-1dbyA:
undetectable
2r5qC-1dbyA:
18.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1e2z CYTOCHROME F

(Chlamydomonas
reinhardtii)
PF01333
(Apocytochr_F_C)
PF16639
(Apocytochr_F_N)
5 LEU A  83
ILE A 244
ILE A  76
VAL A 128
ILE A 130
None
1.10A 2r5qC-1e2zA:
undetectable
2r5qC-1e2zA:
18.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1e6y METHYL-COENZYME M
REDUCTASE I BETA
SUBUNIT


(Methanosarcina
barkeri)
PF02241
(MCR_beta)
PF02783
(MCR_beta_N)
5 LEU B2249
GLY B2263
ILE B2262
VAL B2253
ILE B2252
None
0.92A 2r5qC-1e6yB:
undetectable
2r5qC-1e6yB:
15.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1elj MALTODEXTRIN-BINDING
PROTEIN


(Pyrococcus
furiosus)
PF13416
(SBP_bac_8)
5 LEU A 356
ILE A 190
GLY A 192
ILE A 166
ILE A 355
None
1.08A 2r5qC-1eljA:
undetectable
2r5qC-1eljA:
12.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1fxj UDP-N-ACETYLGLUCOSAM
INE
PYROPHOSPHORYLASE


(Escherichia
coli)
PF00132
(Hexapep)
PF12804
(NTP_transf_3)
5 LEU A 184
ILE A 212
GLY A 127
ILE A 174
ILE A 201
LEU  A 184 ( 0.6A)
ILE  A 212 ( 0.7A)
GLY  A 127 ( 0.0A)
ILE  A 174 ( 0.7A)
ILE  A 201 ( 0.6A)
1.16A 2r5qC-1fxjA:
undetectable
2r5qC-1fxjA:
16.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
GLY A  48
PRO A  81
VAL A  82
ILE A  84
A79  A 800 ( 4.0A)
A79  A 800 (-2.8A)
A79  A 800 (-4.1A)
A79  A 800 ( 3.4A)
A79  A 800 (-4.5A)
A79  A 800 (-3.8A)
0.88A 2r5qC-1hvcA:
13.7
2r5qC-1hvcA:
43.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 LEU A  23
ASP A  25
GLY A  48
VAL A  82
ILE A  84
A79  A 800 ( 3.8A)
A79  A 800 (-2.7A)
A79  A 800 (-3.6A)
A79  A 800 (-4.5A)
A79  A 800 (-3.6A)
0.83A 2r5qC-1hvcA:
13.7
2r5qC-1hvcA:
43.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 LEU A  23
ASP A  25
ILE A  47
GLY A  49
ILE A  50
PRO A  81
VAL A  82
ILE A  84
A79  A 800 ( 3.8A)
A79  A 800 (-2.7A)
A79  A 800 ( 3.2A)
A79  A 800 ( 3.7A)
A79  A 800 (-3.8A)
A79  A 800 ( 3.9A)
A79  A 800 (-4.5A)
A79  A 800 (-3.6A)
0.56A 2r5qC-1hvcA:
13.7
2r5qC-1hvcA:
43.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 LEU A  23
ASP A  25
ILE A  47
GLY A  49
ILE A  50
PRO A  81
VAL A  82
ILE A  84
A79  A 800 ( 4.0A)
A79  A 800 (-2.8A)
A79  A 800 ( 3.4A)
A79  A 800 (-3.4A)
A79  A 800 ( 4.0A)
A79  A 800 ( 3.4A)
A79  A 800 (-4.5A)
A79  A 800 (-3.8A)
0.46A 2r5qC-1hvcA:
13.7
2r5qC-1hvcA:
43.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1id8 METHYLASPARTATE
MUTASE S CHAIN


(Clostridium
tetanomorphum)
PF02310
(B12-binding)
5 LEU A  88
ILE A  37
ILE A  69
VAL A  90
ILE A  58
None
1.18A 2r5qC-1id8A:
undetectable
2r5qC-1id8A:
23.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1lxy ARGININE DEIMINASE

(Mycoplasma
arginini)
PF02274
(Amidinotransf)
5 LEU A  65
ILE A  17
PRO A 402
VAL A  23
ILE A  70
None
1.17A 2r5qC-1lxyA:
undetectable
2r5qC-1lxyA:
14.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1nxu HYPOTHETICAL
OXIDOREDUCTASE YIAK


(Escherichia
coli)
PF02615
(Ldh_2)
5 LEU A 240
ILE A 160
GLY A 134
ILE A 266
ILE A 262
None
1.17A 2r5qC-1nxuA:
undetectable
2r5qC-1nxuA:
14.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1q90 APOCYTOCHROME F

(Chlamydomonas
reinhardtii)
PF01333
(Apocytochr_F_C)
PF16639
(Apocytochr_F_N)
5 LEU A  83
ILE A 244
ILE A  76
VAL A 128
ILE A 130
None
1.17A 2r5qC-1q90A:
undetectable
2r5qC-1q90A:
17.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
7 ARG A   8
LEU A  23
ASP A  25
GLY A  49
ILE A  50
PRO A  81
ILE A  84
None
0.48A 2r5qC-1sivA:
18.8
2r5qC-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
5 LEU A  23
ASP A  25
GLY A  48
PRO A  81
ILE A  84
None
0.83A 2r5qC-1sivA:
18.8
2r5qC-1sivA:
50.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1tkp IRON-RICH
DPSA-HOMOLOG PROTEIN


(Halobacterium
salinarum)
PF00210
(Ferritin)
5 LEU A  81
ASP A  37
ILE A 125
GLY A 127
VAL A  77
None
1.17A 2r5qC-1tkpA:
undetectable
2r5qC-1tkpA:
14.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1vlp NICOTINATE
PHOSPHORIBOSYLTRANSF
ERASE


(Saccharomyces
cerevisiae)
PF04095
(NAPRTase)
5 LEU A 330
ILE A 195
GLY A 212
ILE A 227
ILE A 353
None
1.10A 2r5qC-1vlpA:
undetectable
2r5qC-1vlpA:
13.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1wn1 DIPEPTIDASE

(Pyrococcus
horikoshii)
PF00557
(Peptidase_M24)
PF01321
(Creatinase_N)
5 LEU A 167
ILE A 182
GLY A 217
ILE A 227
VAL A 188
None
1.18A 2r5qC-1wn1A:
undetectable
2r5qC-1wn1A:
15.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1xr4 PUTATIVE CITRATE
LYASE ALPHA
CHAIN/CITRATE-ACP
TRANSFERASE


(Salmonella
enterica)
PF04223
(CitF)
5 LEU A 460
ILE A 250
ILE A 258
VAL A 442
ILE A 440
None
1.15A 2r5qC-1xr4A:
undetectable
2r5qC-1xr4A:
11.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1zmr PHOSPHOGLYCERATE
KINASE


(Escherichia
coli)
PF00162
(PGK)
5 ILE A 188
GLY A 190
PRO A 254
VAL A 253
ILE A 251
None
1.13A 2r5qC-1zmrA:
undetectable
2r5qC-1zmrA:
14.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2c1d SOXA
SOXX


(Paracoccus
denitrificans;
Paracoccus
pantotrophus)
PF00034
(Cytochrom_C)
no annotation
5 ARG A 219
GLY B  49
ILE B  52
VAL B  73
ILE B  67
None
0.99A 2r5qC-2c1dA:
undetectable
2r5qC-2c1dA:
11.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2cev PROTEIN (ARGINASE)

([Bacillus]
caldovelox)
PF00491
(Arginase)
5 LEU A  46
ILE A 101
GLY A 104
PRO A  92
ILE A   7
None
1.19A 2r5qC-2cevA:
undetectable
2r5qC-2cevA:
16.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2f5v PYRANOSE 2-OXIDASE

(Peniophora sp.
SG)
PF05199
(GMC_oxred_C)
5 LEU A 329
ILE A  77
GLY A  53
ILE A  51
VAL A 286
None
FAD  A1625 (-3.9A)
FAD  A1625 (-3.4A)
None
None
1.17A 2r5qC-2f5vA:
undetectable
2r5qC-2f5vA:
10.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
5 ARG A   8
LEU A  23
ASP A  25
ILE A  53
PRO A  86
LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.9A)
0.85A 2r5qC-2fmbA:
15.3
2r5qC-2fmbA:
34.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
6 LEU A  23
ASP A  25
GLY A  54
PRO A  86
VAL A  87
ILE A  89
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
0.97A 2r5qC-2fmbA:
15.3
2r5qC-2fmbA:
34.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
7 LEU A  23
ASP A  25
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
None
LP1  A 201 (-2.3A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
0.59A 2r5qC-2fmbA:
15.3
2r5qC-2fmbA:
34.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2glx 1,5-ANHYDRO-D-FRUCTO
SE REDUCTASE


(Ensifer
adhaerens)
PF01408
(GFO_IDH_MocA)
PF02894
(GFO_IDH_MocA_C)
5 LEU A 287
ILE A  48
ILE A   7
VAL A  17
ILE A  21
None
1.08A 2r5qC-2glxA:
undetectable
2r5qC-2glxA:
15.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2j6l ALDEHYDE
DEHYDROGENASE FAMILY
7 MEMBER A1


(Homo sapiens)
PF00171
(Aldedh)
5 LEU A 242
ILE A 220
ILE A 183
PRO A 157
VAL A 158
None
1.14A 2r5qC-2j6lA:
undetectable
2r5qC-2j6lA:
12.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2lnv GENERAL SECRETION
PATHWAY PROTEIN C


(Dickeya
dadantii)
PF11356
(T2SSC)
5 LEU A 145
ILE A 110
PRO A 129
VAL A 128
ILE A 135
None
1.03A 2r5qC-2lnvA:
undetectable
2r5qC-2lnvA:
19.23
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ARG A   8
LEU A  23
ASP A  25
GLY A  49
ILE A  50
PRO A  81
ILE A  84
AB1  A 501 ( 4.7A)
None
AB1  A 501 (-2.4A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
AB1  A 501 (-4.2A)
AB1  A 501 ( 4.2A)
0.79A 2r5qC-2rkfA:
19.8
2r5qC-2rkfA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 LEU A  23
ASP A  25
GLY A  48
PRO A  81
ILE A  84
None
AB1  A 501 (-2.4A)
AB1  A 501 (-4.2A)
AB1  A 501 (-4.2A)
AB1  A 501 ( 4.2A)
0.92A 2r5qC-2rkfA:
19.8
2r5qC-2rkfA:
76.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2xwu IMPORTIN13

(Homo sapiens)
PF03810
(IBN_N)
PF08389
(Xpo1)
5 LEU B 610
ILE B 640
GLY B 642
VAL B 680
ILE B 614
None
1.06A 2r5qC-2xwuB:
undetectable
2r5qC-2xwuB:
7.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ynm LIGHT-INDEPENDENT
PROTOCHLOROPHYLLIDE
REDUCTASE SUBUNIT B
LIGHT-INDEPENDENT
PROTOCHLOROPHYLLIDE
REDUCTASE SUBUNIT N


(Prochlorococcus
marinus)
PF00148
(Oxidored_nitro)
PF08369
(PCP_red)
5 ARG D  52
LEU C 348
ASP C 349
PRO C  12
VAL C 344
None
0.94A 2r5qC-2ynmD:
undetectable
2r5qC-2ynmD:
11.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2zj4 GLUCOSAMINE--FRUCTOS
E-6-PHOSPHATE
AMINOTRANSFERASE
[ISOMERIZING] 1


(Homo sapiens)
PF01380
(SIS)
5 ILE A 634
ILE A 592
PRO A 615
VAL A 588
ILE A 589
None
1.17A 2r5qC-2zj4A:
undetectable
2r5qC-2zj4A:
15.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ail 303AA LONG
HYPOTHETICAL
ESTERASE


(Sulfurisphaera
tokodaii)
PF07859
(Abhydrolase_3)
5 ARG A 221
LEU A 162
ILE A  50
GLY A  52
VAL A 121
PO4  A 306 (-2.8A)
None
None
None
None
1.14A 2r5qC-3ailA:
undetectable
2r5qC-3ailA:
15.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3b54 NUCLEOSIDE
DIPHOSPHATE KINASE


(Saccharomyces
cerevisiae)
PF00334
(NDK)
5 ARG A  19
ILE A  91
GLY A 103
VAL A 117
ILE A  25
None
1.19A 2r5qC-3b54A:
undetectable
2r5qC-3b54A:
23.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3b8y ENDO-PECTATE LYASE

(Dickeya
chrysanthemi)
PF03211
(Pectate_lyase)
5 LEU A 153
ILE A 206
GLY A 209
ILE A 188
ILE A 175
None
1.01A 2r5qC-3b8yA:
undetectable
2r5qC-3b8yA:
17.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3b90 ENDO-PECTATE LYASE

(Dickeya
chrysanthemi)
PF03211
(Pectate_lyase)
5 LEU A 153
ILE A 206
GLY A 209
ILE A 188
ILE A 175
None
1.12A 2r5qC-3b90A:
undetectable
2r5qC-3b90A:
22.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3bxw CHITINASE
DOMAIN-CONTAINING
PROTEIN 1


(Homo sapiens)
no annotation 5 LEU B 277
ILE B  84
GLY B  78
VAL B 355
ILE B 357
None
1.17A 2r5qC-3bxwB:
undetectable
2r5qC-3bxwB:
13.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3cs3 SUGAR-BINDING
TRANSCRIPTIONAL
REGULATOR, LACI
FAMILY


(Enterococcus
faecalis)
PF13377
(Peripla_BP_3)
5 LEU A 195
ILE A 279
GLY A 262
ILE A 260
ILE A 161
None
1.07A 2r5qC-3cs3A:
undetectable
2r5qC-3cs3A:
18.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3dkn PREPROTEIN
TRANSLOCASE SUBUNIT
SECY


(Canis lupus)
PF00344
(SecY)
5 ILE A 160
GLY A 165
ILE A 166
VAL A  35
ILE A  32
None
1.15A 2r5qC-3dknA:
undetectable
2r5qC-3dknA:
14.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3efb PROBABLE SOR-OPERON
REGULATOR


(Shigella
flexneri)
PF04198
(Sugar-bind)
5 LEU A  57
GLY A 230
ILE A 231
VAL A  63
ILE A 157
None
1.06A 2r5qC-3efbA:
undetectable
2r5qC-3efbA:
16.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3euj CHROMOSOME PARTITION
PROTEIN MUKB, LINKER


([Haemophilus]
ducreyi)
PF04310
(MukB)
PF13558
(SbcCD_C)
5 LEU A1290
GLY A1396
ILE A1399
VAL A1301
ILE A1293
None
1.02A 2r5qC-3eujA:
undetectable
2r5qC-3eujA:
14.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hd6 AMMONIUM TRANSPORTER
RH TYPE C


(Homo sapiens)
PF00909
(Ammonium_transp)
5 LEU A 332
ILE A 340
GLY A 345
ILE A 346
ILE A 334
None
1.15A 2r5qC-3hd6A:
undetectable
2r5qC-3hd6A:
13.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3i24 HIT FAMILY HYDROLASE

(Aliivibrio
fischeri)
PF01230
(HIT)
5 LEU A   9
ILE A  80
PRO A  39
VAL A  38
ILE A  36
None
None
NA  A 157 (-4.1A)
NA  A 157 ( 4.7A)
None
1.16A 2r5qC-3i24A:
undetectable
2r5qC-3i24A:
25.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3iib PEPTIDASE M28

(Shewanella
amazonensis)
PF04389
(Peptidase_M28)
5 LEU A 139
ILE A 133
GLY A 191
ILE A 219
ILE A 157
None
1.19A 2r5qC-3iibA:
undetectable
2r5qC-3iibA:
13.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ipl 2-SUCCINYLBENZOATE--
COA LIGASE


(Staphylococcus
aureus)
PF00501
(AMP-binding)
PF13193
(AMP-binding_C)
5 LEU A 349
ASP A 379
GLY A 280
VAL A 389
ILE A 391
None
1.04A 2r5qC-3iplA:
undetectable
2r5qC-3iplA:
12.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ipl 2-SUCCINYLBENZOATE--
COA LIGASE


(Staphylococcus
aureus)
PF00501
(AMP-binding)
PF13193
(AMP-binding_C)
5 LEU A 349
ASP A 379
GLY A 281
VAL A 389
ILE A 391
None
1.05A 2r5qC-3iplA:
undetectable
2r5qC-3iplA:
12.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3k7x LIN0763 PROTEIN

(Listeria
innocua)
PF03663
(Glyco_hydro_76)
5 LEU A  56
ASP A  57
GLY A 269
ILE A 270
VAL A  52
None
1.19A 2r5qC-3k7xA:
undetectable
2r5qC-3k7xA:
16.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3kf3 INVERTASE

(Schwanniomyces
occidentalis)
PF00251
(Glyco_hydro_32N)
PF08244
(Glyco_hydro_32C)
5 ILE A 413
GLY A 479
ILE A 480
PRO A 509
ILE A 427
None
1.13A 2r5qC-3kf3A:
undetectable
2r5qC-3kf3A:
11.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3kzg ARGININE 3RD
TRANSPORT SYSTEM
PERIPLASMIC BINDING
PROTEIN


(Legionella
pneumophila)
PF00497
(SBP_bac_3)
5 ASP A  46
GLY A 208
ILE A  88
VAL A  83
ILE A  84
None
0.91A 2r5qC-3kzgA:
undetectable
2r5qC-3kzgA:
17.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3l6r SERINE RACEMASE

(Homo sapiens)
PF00291
(PALP)
5 LEU A 180
ILE A 160
GLY A 162
VAL A 197
ILE A 193
None
1.06A 2r5qC-3l6rA:
undetectable
2r5qC-3l6rA:
16.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ARG A   8
LEU A  23
ASP A  25
ILE A  47
GLY A  49
ILE A  50
PRO A  81
VAL A  82
ILE A  84
None
0.61A 2r5qC-3mwsA:
20.6
2r5qC-3mwsA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
GLY A  48
PRO A  81
VAL A  82
ILE A  84
None
0.89A 2r5qC-3mwsA:
20.6
2r5qC-3mwsA:
76.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3nh9 ATP-BINDING CASSETTE
SUB-FAMILY B MEMBER
6, MITOCHONDRIAL


(Homo sapiens)
PF00005
(ABC_tran)
5 LEU A 769
ILE A 684
GLY A 687
VAL A 772
ILE A 737
BME  A   3 ( 4.9A)
None
None
None
None
1.13A 2r5qC-3nh9A:
undetectable
2r5qC-3nh9A:
16.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ARG A   8
LEU A  23
ASP A  25
ILE A  47
GLY A  49
ILE A  50
SO4  A 101 (-3.8A)
SO4  A 101 (-4.2A)
017  A 201 (-2.6A)
None
017  A 201 (-4.0A)
017  A 201 (-3.3A)
0.83A 2r5qC-3t3cA:
19.3
2r5qC-3t3cA:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ARG A   8
LEU A  23
ASP A  25
ILE A  47
GLY A  49
PRO A  81
SO4  A 101 (-3.8A)
SO4  A 101 (-4.2A)
017  A 201 (-2.6A)
None
017  A 201 (-4.0A)
None
1.07A 2r5qC-3t3cA:
19.3
2r5qC-3t3cA:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ttp HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ARG A   8
LEU A  23
ASP A  25
GLY A  49
ILE A  50
PRO A  81
ILE A  84
017  A 201 ( 4.8A)
None
017  A 201 (-2.6A)
017  A 201 (-3.0A)
017  A 201 (-3.3A)
017  A 201 (-4.1A)
017  A 201 (-4.7A)
0.69A 2r5qC-3ttpA:
19.7
2r5qC-3ttpA:
76.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3u4y UNCHARACTERIZED
PROTEIN


(Desulfotomaculum
acetoxidans)
PF10282
(Lactonase)
5 ASP A 143
ILE A 197
GLY A 171
ILE A 169
ILE A 178
None
1.16A 2r5qC-3u4yA:
undetectable
2r5qC-3u4yA:
18.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3u7s POL POLYPROTEIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ARG A   8
LEU A  23
ASP A  25
ILE A  47
GLY A  49
ILE A  50
PRO A  81
None
None
017  A 202 ( 2.5A)
017  A 202 (-3.6A)
017  A 202 (-2.9A)
017  A 201 ( 3.5A)
017  A 202 (-4.0A)
0.78A 2r5qC-3u7sA:
19.9
2r5qC-3u7sA:
75.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3vr5 V-TYPE SODIUM ATPASE
CATALYTIC SUBUNIT A


(Enterococcus
hirae)
PF00006
(ATP-synt_ab)
PF02874
(ATP-synt_ab_N)
PF16886
(ATP-synt_ab_Xtn)
6 ARG A 197
LEU A  75
ILE A 173
GLY A 137
ILE A 135
PRO A 152
None
1.28A 2r5qC-3vr5A:
undetectable
2r5qC-3vr5A:
10.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3vti HYDROGENASE
MATURATION FACTOR


(Caldanaerobacter
subterraneus)
PF00586
(AIRS)
PF02769
(AIRS_C)
5 LEU C 234
ILE C 257
GLY C 319
ILE C 317
VAL C 290
None
1.17A 2r5qC-3vtiC:
undetectable
2r5qC-3vtiC:
14.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4bof ARGININE DEIMINASE

(Streptococcus
pyogenes)
PF02274
(Amidinotransf)
5 LEU A  61
ILE A  13
PRO A 405
VAL A  19
ILE A  66
None
1.11A 2r5qC-4bofA:
undetectable
2r5qC-4bofA:
13.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4c98 CAS6B

(Thermus
thermophilus)
PF10040
(CRISPR_Cas6)
5 ARG A  71
LEU A 260
ILE A 164
PRO A 263
VAL A 262
None
1.14A 2r5qC-4c98A:
undetectable
2r5qC-4c98A:
16.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4dz6 NUCLEOSIDE
DIPHOSPHATE KINASE


(Borreliella
burgdorferi)
PF00334
(NDK)
5 ARG A  19
LEU A  21
ASP A  24
GLY A 108
VAL A 132
None
1.17A 2r5qC-4dz6A:
undetectable
2r5qC-4dz6A:
22.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4e4j ARGININE DEIMINASE

(Mycoplasma
penetrans)
PF02274
(Amidinotransf)
5 LEU A 109
ILE A  61
PRO A 444
VAL A  67
ILE A 114
None
1.17A 2r5qC-4e4jA:
undetectable
2r5qC-4e4jA:
12.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ehi BIFUNCTIONAL PURINE
BIOSYNTHESIS PROTEIN
PURH


(Campylobacter
jejuni)
PF01808
(AICARFT_IMPCHas)
PF02142
(MGS)
5 LEU A 154
GLY A  12
ILE A  13
VAL A 150
ILE A 151
None
1.10A 2r5qC-4ehiA:
undetectable
2r5qC-4ehiA:
10.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ehj PHOSPHOGLYCERATE
KINASE


(Francisella
tularensis)
PF00162
(PGK)
5 ILE A 188
GLY A 190
PRO A 259
VAL A 258
ILE A 256
None
1.06A 2r5qC-4ehjA:
undetectable
2r5qC-4ehjA:
14.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4jlr MOTAVIZUMAB FAB
HEAVY CHAIN


(Homo sapiens)
no annotation 5 LEU H  18
ILE H  51
GLY H  35
ILE H  37
VAL H  82
None
1.14A 2r5qC-4jlrH:
undetectable
2r5qC-4jlrH:
19.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4m1q L-LACTATE
DEHYDROGENASE


([Bacillus]
selenitireducens)
PF00056
(Ldh_1_N)
PF02866
(Ldh_1_C)
5 LEU A 243
ILE A 173
GLY A 175
ILE A 272
ILE A 148
None
1.18A 2r5qC-4m1qA:
undetectable
2r5qC-4m1qA:
15.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 LEU A  23
ASP A  25
GLY A  48
PRO A  81
ILE A  84
None
RIT  A 500 (-2.4A)
RIT  A 500 (-4.8A)
RIT  A 500 (-3.9A)
RIT  A 500 (-4.3A)
0.83A 2r5qC-4njvA:
20.1
2r5qC-4njvA:
82.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 LEU A  23
ASP A  25
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
None
RIT  A 500 (-2.4A)
RIT  A 500 ( 4.5A)
RIT  A 500 (-3.4A)
RIT  A 500 (-4.3A)
RIT  A 500 (-3.9A)
RIT  A 500 (-4.3A)
0.49A 2r5qC-4njvA:
20.1
2r5qC-4njvA:
82.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4nqy ISOPROPYLMALATE/CITR
AMALATE ISOMERASE
LARGE SUBUNIT


(Methanocaldococcus
jannaschii)
PF00330
(Aconitase)
5 ASP A  65
ILE A  62
GLY A  39
ILE A  37
VAL A 101
None
1.19A 2r5qC-4nqyA:
undetectable
2r5qC-4nqyA:
14.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4pxq D-GLUCURONYL C5
EPIMERASE B


(Danio rerio)
PF06662
(C5-epim_C)
5 LEU A 322
ASP A 325
GLY A 308
VAL A 276
ILE A 289
None
1.11A 2r5qC-4pxqA:
undetectable
2r5qC-4pxqA:
9.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4q6g PYRROLYSINE--TRNA
LIGASE


(Methanosarcina
mazei)
PF01409
(tRNA-synt_2d)
5 ASP A 408
ILE A 305
GLY A 419
ILE A 418
ILE A 413
None
ALY  A 508 ( 4.6A)
ALY  A 508 ( 4.3A)
None
EDO  A 506 ( 4.7A)
1.10A 2r5qC-4q6gA:
undetectable
2r5qC-4q6gA:
17.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4qme AMINOPEPTIDASE N

(Neisseria
meningitidis)
PF01433
(Peptidase_M1)
PF11940
(DUF3458)
PF17432
(DUF3458_C)
5 LEU A  49
GLY A  64
PRO A  82
VAL A  81
ILE A  78
None
1.08A 2r5qC-4qmeA:
undetectable
2r5qC-4qmeA:
6.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4qpm MITOTIC CHECKPOINT
SERINE/THREONINE-PRO
TEIN KINASE BUB1


(Homo sapiens)
PF00069
(Pkinase)
5 ASP A 987
ILE A 833
GLY A 948
PRO A 741
ILE A 914
None
None
MG  A1503 ( 4.6A)
None
None
1.11A 2r5qC-4qpmA:
undetectable
2r5qC-4qpmA:
14.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4wbt PROBABLE
HISTIDINOL-PHOSPHATE
AMINOTRANSFERASE


(Sinorhizobium
meliloti)
PF00155
(Aminotran_1_2)
5 LEU A 104
ILE A  94
GLY A 236
ILE A  90
ILE A 101
None
PLP  A 401 (-3.6A)
None
None
None
1.19A 2r5qC-4wbtA:
undetectable
2r5qC-4wbtA:
15.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4xqk LLABIII

(Lactococcus
lactis)
PF00271
(Helicase_C)
PF02384
(N6_Mtase)
PF04851
(ResIII)
PF13156
(Mrr_cat_2)
5 ILE A 666
GLY A 466
ILE A 463
VAL A 614
ILE A 613
None
1.15A 2r5qC-4xqkA:
undetectable
2r5qC-4xqkA:
4.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4xwh ALPHA-N-ACETYLGLUCOS
AMINIDASE


(Homo sapiens)
PF05089
(NAGLU)
PF12971
(NAGLU_N)
PF12972
(NAGLU_C)
5 LEU A 281
GLY A 183
PRO A 250
VAL A 249
ILE A 291
None
1.13A 2r5qC-4xwhA:
undetectable
2r5qC-4xwhA:
8.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4yry DIHYDROPYRIMIDINE
DEHYDROGENASE
SUBUNIT A


(Thermotoga
maritima)
PF07992
(Pyr_redox_2)
PF14691
(Fer4_20)
5 ILE B 113
GLY B  87
PRO B  52
VAL B  53
ILE B  55
SF4  B 502 ( 4.8A)
None
SF4  B 502 ( 4.9A)
None
SF4  B 502 ( 4.4A)
1.18A 2r5qC-4yryB:
undetectable
2r5qC-4yryB:
13.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ywl CELL DIVISION
CONTROL PROTEIN 21


(Pyrococcus
furiosus)
PF14551
(MCM_N)
PF17207
(MCM_OB)
5 ILE A 187
GLY A 205
ILE A 206
VAL A 214
ILE A 249
None
1.02A 2r5qC-4ywlA:
undetectable
2r5qC-4ywlA:
17.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5bn4 V-TYPE ATP SYNTHASE
ALPHA CHAIN


(Nanoarchaeum
equitans)
PF00006
(ATP-synt_ab)
PF02874
(ATP-synt_ab_N)
PF16886
(ATP-synt_ab_Xtn)
5 ARG A 188
LEU A  71
ILE A 168
GLY A 133
ILE A 131
None
0.95A 2r5qC-5bn4A:
undetectable
2r5qC-5bn4A:
11.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5css TRIOSEPHOSPHATE
ISOMERASE


(Thermoplasma
acidophilum)
PF00121
(TIM)
5 LEU A   8
ILE A 142
GLY A 173
ILE A 193
VAL A 200
None
G3P  A 301 (-4.0A)
None
None
None
1.13A 2r5qC-5cssA:
undetectable
2r5qC-5cssA:
20.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5d86 PROBABLE SIDEROPHORE
BIOSYNTHESIS PROTEIN
SBNA


(Staphylococcus
aureus)
PF00291
(PALP)
5 ILE A 229
GLY A 274
ILE A 277
VAL A 207
ILE A 247
None
1.18A 2r5qC-5d86A:
undetectable
2r5qC-5d86A:
17.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5iq6 RNA DEPENDENT RNA
POLYMERASE


(Dengue virus)
PF00972
(Flavi_NS5)
5 LEU A 724
ILE A 517
GLY A 510
PRO A 727
VAL A 726
None
1.17A 2r5qC-5iq6A:
undetectable
2r5qC-5iq6A:
11.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5k6o B-GLUCOSIDASE

(metagenome)
PF00933
(Glyco_hydro_3)
PF01915
(Glyco_hydro_3_C)
PF14310
(Fn3-like)
5 LEU A 554
ILE A 663
GLY A 668
PRO A 585
ILE A 612
None
1.07A 2r5qC-5k6oA:
undetectable
2r5qC-5k6oA:
7.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5kk5 CRISPR-ASSOCIATED
ENDONUCLEASE CPF1


(Acidaminococcus
sp. BV3L6)
no annotation 5 LEU A  66
ILE A 121
GLY A 112
ILE A 111
VAL A  69
None
1.16A 2r5qC-5kk5A:
undetectable
2r5qC-5kk5A:
6.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5n9m COBYRIC ACID
SYNTHASE


(Staphylococcus
aureus)
no annotation 5 LEU A 203
ILE A 135
GLY A 177
ILE A 178
ILE A 199
None
1.09A 2r5qC-5n9mA:
undetectable
2r5qC-5n9mA:
20.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ogz -

(-)
no annotation 6 LEU A 154
GLY A 112
ILE A 113
PRO A 159
VAL A 158
ILE A 157
None
1.19A 2r5qC-5ogzA:
undetectable
2r5qC-5ogzA:
undetectable
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5t2z PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ARG A   8
LEU A  23
ASP A  25
ILE A  50
PRO A  81
None
0.93A 2r5qC-5t2zA:
19.2
2r5qC-5t2zA:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5t2z PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 LEU A  23
ASP A  25
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
None
0.65A 2r5qC-5t2zA:
19.2
2r5qC-5t2zA:
75.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5t5i TUNGSTEN
FORMYLMETHANOFURAN
DEHYDROGENASE
SUBUNIT FWDG


(Methanothermobacter
wolfeii)
PF12838
(Fer4_7)
5 LEU G  60
ILE G  76
PRO G  23
VAL G  24
ILE G  45
None
SF4  G 101 ( 3.8A)
None
None
SF4  G 102 ( 3.9A)
1.12A 2r5qC-5t5iG:
undetectable
2r5qC-5t5iG:
27.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5x09 V-TYPE ATP SYNTHASE
ALPHA CHAIN,V-TYPE
ATP SYNTHASE ALPHA
CHAIN


(Pyrococcus
horikoshii)
no annotation 5 ARG A 199
LEU A  76
ILE A 174
GLY A 137
ILE A 135
None
1.00A 2r5qC-5x09A:
undetectable
2r5qC-5x09A:
12.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ze4 DIHYDROXY-ACID
DEHYDRATASE,
CHLOROPLASTIC


(Arabidopsis
thaliana)
no annotation 5 ILE A 121
GLY A  55
ILE A  54
VAL A 160
ILE A 136
None
1.13A 2r5qC-5ze4A:
undetectable
2r5qC-5ze4A:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6eki CARBONIC ANHYDRASE

(Persephonella
marina)
no annotation 6 ARG A 247
ILE A 152
GLY A 150
PRO A  62
VAL A  63
ILE A  65
None
1.27A 2r5qC-6ekiA:
undetectable
2r5qC-6ekiA:
19.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
5 ARG A   8
LEU A  23
ASP A  25
GLY A  49
ILE A  84
None
None
NIU  A 100 (-2.8A)
NIU  A 100 ( 3.8A)
None
0.80A 2r5qC-6upjA:
18.1
2r5qC-6upjA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
5 LEU A  23
ASP A  25
GLY A  49
PRO A  81
ILE A  84
None
NIU  A 100 (-2.8A)
NIU  A 100 ( 3.8A)
None
None
0.72A 2r5qC-6upjA:
18.1
2r5qC-6upjA:
50.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1bqc PROTEIN
(BETA-MANNANASE)


(Thermobifida
fusca)
PF00150
(Cellulase)
5 GLY A 227
ILE A 195
GLY A 224
ILE A 252
ILE A 240
None
0.89A 2r5qD-1bqcA:
0.0
2r5qD-1bqcA:
15.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1bsg BETA LACTAMASE

(Streptomyces
albus)
PF13354
(Beta-lactamase2)
5 GLY A 248
ALA A 247
ASP A 246
ILE A 127
ILE A 186
None
0.91A 2r5qD-1bsgA:
0.0
2r5qD-1bsgA:
16.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1czi CHYMOSIN

(Bos taurus)
PF00026
(Asp)
5 ASP E  32
GLY E  34
ASP E  37
ILE E  73
ILE E 120
None
0.89A 2r5qD-1cziE:
6.9
2r5qD-1cziE:
18.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1g0v PROTEASE A INHIBITOR
3
PROTEINASE A


(Saccharomyces
cerevisiae)
PF00026
(Asp)
PF10466
(Inhibitor_I34)
5 ASP A  32
GLY A  34
ILE A  73
GLY B  21
ILE A 120
None
0.90A 2r5qD-1g0vA:
7.6
2r5qD-1g0vA:
16.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1gz5 ALPHA-TREHALOSE-PHOS
PHATE SYNTHASE


(Escherichia
coli)
PF00982
(Glyco_transf_20)
5 GLY A 389
ALA A 390
ILE A 434
GLY A 226
ILE A 225
None
None
None
None
IMD  A 902 ( 4.3A)
0.88A 2r5qD-1gz5A:
undetectable
2r5qD-1gz5A:
12.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ALA A  28
ASP A  29
ASP A  30
GLY A  48
ILE A  84
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 ( 4.9A)
A79  A 800 (-3.6A)
A79  A 800 (-3.6A)
0.81A 2r5qD-1hvcA:
17.4
2r5qD-1hvcA:
43.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ALA A  28
ASP A  29
ASP A  30
GLY A  48
PRO A  81
ILE A  84
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 ( 4.7A)
A79  A 800 (-4.1A)
A79  A 800 ( 3.4A)
A79  A 800 (-3.8A)
0.95A 2r5qD-1hvcA:
17.4
2r5qD-1hvcA:
43.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
A79  A 800 (-2.7A)
A79  A 800 (-3.0A)
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 ( 4.9A)
A79  A 800 ( 3.2A)
A79  A 800 ( 3.7A)
A79  A 800 (-3.8A)
A79  A 800 ( 3.9A)
A79  A 800 (-3.6A)
0.60A 2r5qD-1hvcA:
17.4
2r5qD-1hvcA:
43.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
A79  A 800 (-2.8A)
A79  A 800 (-3.0A)
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 ( 4.7A)
A79  A 800 ( 3.4A)
A79  A 800 (-3.4A)
A79  A 800 ( 4.0A)
A79  A 800 ( 3.4A)
A79  A 800 (-3.8A)
0.59A 2r5qD-1hvcA:
17.4
2r5qD-1hvcA:
43.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1j2b ARCHAEOSINE
TRNA-GUANINE
TRANSGLYCOSYLASE


(Pyrococcus
horikoshii)
PF01472
(PUA)
PF01702
(TGT)
PF14809
(TGT_C1)
PF14810
(TGT_C2)
5 ASP A 535
GLY A 537
ASP A 542
GLY A 449
PRO A 504
None
0.89A 2r5qD-1j2bA:
undetectable
2r5qD-1j2bA:
11.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1j71 ASPARTIC PROTEINASE

(Candida
tropicalis)
PF00026
(Asp)
5 ASP A  32
GLY A  34
ASP A  37
ILE A  82
ILE A 123
None
0.84A 2r5qD-1j71A:
7.7
2r5qD-1j71A:
17.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1kpl PUTATIVE CLC FAMILY,
CHLORINE TRANSPORT
PROTEIN


(Salmonella
enterica)
PF00654
(Voltage_CLC)
5 GLY A 181
ALA A 182
ILE A 109
PRO A 206
ILE A 200
None
0.85A 2r5qD-1kplA:
undetectable
2r5qD-1kplA:
13.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1kz1 6,7-DIMETHYL-8-RIBIT
YLLUMAZINE SYNTHASE


(Schizosaccharomyces
pombe)
PF00885
(DMRL_synthase)
5 GLY A 147
ALA A 150
GLY A  83
ILE A  84
ILE A  20
None
0.94A 2r5qD-1kz1A:
undetectable
2r5qD-1kz1A:
26.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1l5j ACONITATE HYDRATASE
2


(Escherichia
coli)
PF00330
(Aconitase)
PF06434
(Aconitase_2_N)
PF11791
(Aconitase_B_N)
5 GLY A 721
ALA A 720
GLY A 715
ILE A 714
ILE A 707
None
0.90A 2r5qD-1l5jA:
undetectable
2r5qD-1l5jA:
9.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1mpp PEPSIN

(Rhizomucor
pusillus)
PF00026
(Asp)
5 ASP A  32
GLY A  34
ASP A  37
ILE A  73
ILE A 120
None
0.66A 2r5qD-1mppA:
7.4
2r5qD-1mppA:
13.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1nq3 14.3 KDA PERCHLORIC
ACID SOLUBLE PROTEIN


(Capra hircus)
PF01042
(Ribonuc_L-PSP)
5 GLY A  70
ALA A  69
ILE A  65
GLY A  63
ILE A  31
None
0.90A 2r5qD-1nq3A:
undetectable
2r5qD-1nq3A:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1oni 14.5 KDA
TRANSLATIONAL
INHIBITOR PROTEIN


(Homo sapiens)
PF01042
(Ribonuc_L-PSP)
5 GLY A  70
ALA A  69
ILE A  65
GLY A  63
ILE A  31
None
0.82A 2r5qD-1oniA:
undetectable
2r5qD-1oniA:
22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1p2f RESPONSE REGULATOR

(Thermotoga
maritima)
PF00072
(Response_reg)
PF00486
(Trans_reg_C)
5 GLY A  93
ALA A  94
ASP A  95
ILE A  75
ILE A  61
None
0.85A 2r5qD-1p2fA:
undetectable
2r5qD-1p2fA:
19.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1q9p HIV-1 PROTEASE

(Homo sapiens)
PF00077
(RVP)
6 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
None
0.65A 2r5qD-1q9pA:
10.0
2r5qD-1q9pA:
89.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1q9p HIV-1 PROTEASE

(Homo sapiens)
PF00077
(RVP)
6 ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
ILE A  84
None
0.89A 2r5qD-1q9pA:
10.0
2r5qD-1q9pA:
89.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1qah PERCHLORIC ACID
SOLUBLE PROTEIN


(Rattus
norvegicus)
PF01042
(Ribonuc_L-PSP)
5 GLY A  69
ALA A  68
ILE A  64
GLY A  62
ILE A  30
None
0.76A 2r5qD-1qahA:
undetectable
2r5qD-1qahA:
21.01
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
6 ALA A  28
ASP A  29
ASP A  30
GLY A  48
PRO A  81
ILE A  84
None
0.99A 2r5qD-1sivA:
18.5
2r5qD-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
None
0.50A 2r5qD-1sivA:
18.5
2r5qD-1sivA:
50.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1to6 GLYCERATE KINASE

(Neisseria
meningitidis)
PF02595
(Gly_kinase)
5 ALA A 190
ASP A 191
GLY A 244
ILE A 247
ILE A 259
None
None
SO4  A 373 (-3.5A)
None
None
0.94A 2r5qD-1to6A:
undetectable
2r5qD-1to6A:
14.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2bc0 NADH OXIDASE

(Streptococcus
pyogenes)
PF02852
(Pyr_redox_dim)
PF07992
(Pyr_redox_2)
5 GLY A 453
ALA A 454
ASP A 456
ILE A 387
ILE A 426
None
0.80A 2r5qD-2bc0A:
undetectable
2r5qD-2bc0A:
12.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2eja UROPORPHYRINOGEN
DECARBOXYLASE


(Aquifex
aeolicus)
PF01208
(URO-D)
5 GLY A 192
ALA A 193
ASP A 194
ILE A 134
ILE A 120
None
0.82A 2r5qD-2ejaA:
undetectable
2r5qD-2ejaA:
13.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ewn BIRA BIFUNCTIONAL
PROTEIN


(Escherichia
coli)
PF02237
(BPL_C)
PF03099
(BPL_LplA_LipB)
PF08279
(HTH_11)
5 GLY A 186
ALA A 185
GLY A 154
ILE A 153
ILE A 207
BTX  A 501 (-3.3A)
None
None
None
None
0.87A 2r5qD-2ewnA:
undetectable
2r5qD-2ewnA:
17.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2f6g HTH-TYPE
TRANSCRIPTIONAL
REGULATOR BENM


(Acinetobacter
baylyi)
PF03466
(LysR_substrate)
6 GLY A 143
ALA A 142
ASP A 141
ILE A  92
ILE A 108
ILE A 282
None
1.37A 2r5qD-2f6gA:
undetectable
2r5qD-2f6gA:
21.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
6 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  54
ILE A  89
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
0.88A 2r5qD-2fmbA:
14.9
2r5qD-2fmbA:
34.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
8 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
PRO A  86
ILE A  89
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
0.32A 2r5qD-2fmbA:
14.9
2r5qD-2fmbA:
34.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2g3n ALPHA-GLUCOSIDASE

(Sulfolobus
solfataricus)
PF01055
(Glyco_hydro_31)
PF13802
(Gal_mutarotas_2)
5 GLY A 115
ILE A 102
GLY A  66
ILE A  65
PRO A 528
None
0.83A 2r5qD-2g3nA:
undetectable
2r5qD-2g3nA:
10.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2iny HEXON PROTEIN

(Fowl
aviadenovirus A)
PF01065
(Adeno_hexon)
PF03678
(Adeno_hexon_C)
5 GLY A 184
ALA A 194
ASP A 195
ILE A 174
ILE A 199
None
0.88A 2r5qD-2inyA:
undetectable
2r5qD-2inyA:
7.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2isq CYSTEINE SYNTHASE

(Arabidopsis
thaliana)
PF00291
(PALP)
5 GLY A 190
ALA A 189
GLY A 183
ILE A 180
PRO A 296
None
None
PLP  A 400 (-3.4A)
PLP  A 400 (-4.9A)
PLP  A 400 (-4.0A)
0.75A 2r5qD-2isqA:
undetectable
2r5qD-2isqA:
17.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2o7q BIFUNCTIONAL
3-DEHYDROQUINATE
DEHYDRATASE/SHIKIMAT
E DEHYDROGENASE


(Arabidopsis
thaliana)
PF01487
(DHquinase_I)
PF01488
(Shikimate_DH)
PF08501
(Shikimate_dh_N)
5 GLY A 236
ALA A 237
ASP A 238
ILE A 210
ILE A 232
None
0.83A 2r5qD-2o7qA:
undetectable
2r5qD-2o7qA:
12.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qzw CANDIDAPEPSIN-1

(Candida
albicans)
PF00026
(Asp)
5 ASP A  32
GLY A  34
ASP A  37
ILE A  82
ILE A 123
None
0.74A 2r5qD-2qzwA:
7.9
2r5qD-2qzwA:
13.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qzx CANDIDAPEPSIN-5

(Candida
albicans)
PF00026
(Asp)
5 ASP A  32
GLY A  34
ASP A  37
ILE A  82
ILE A 123
None
0.89A 2r5qD-2qzxA:
7.8
2r5qD-2qzxA:
15.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ALA A  28
ASP A  29
ASP A  30
GLY A  48
PRO A  81
ILE A  84
AB1  A 501 (-3.5A)
AB1  A 501 ( 3.3A)
AB1  A 501 (-3.8A)
AB1  A 501 (-4.2A)
AB1  A 501 (-4.2A)
AB1  A 501 ( 4.2A)
0.94A 2r5qD-2rkfA:
19.9
2r5qD-2rkfA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
AB1  A 501 (-2.4A)
AB1  A 501 (-3.9A)
AB1  A 501 (-3.5A)
AB1  A 501 ( 3.3A)
AB1  A 501 (-3.8A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
AB1  A 501 (-4.2A)
AB1  A 501 ( 4.2A)
0.44A 2r5qD-2rkfA:
19.9
2r5qD-2rkfA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rsp RSV PROTEASE

(Rous sarcoma
virus)
PF00077
(RVP)
5 ASP A  37
GLY A  39
ALA A  40
ASP A  41
ILE A 108
None
0.28A 2r5qD-2rspA:
12.6
2r5qD-2rspA:
34.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2xxl GRAM-POSITIVE
SPECIFIC SERINE
PROTEASE, ISOFORM B


(Drosophila
melanogaster)
PF00089
(Trypsin)
PF12032
(CLIP)
5 GLY A 150
ALA A 134
ILE A 239
ILE A 153
ILE A 175
None
0.94A 2r5qD-2xxlA:
undetectable
2r5qD-2xxlA:
13.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2y9e MYOSIN-2

(Dictyostelium
discoideum)
PF00063
(Myosin_head)
PF02736
(Myosin_N)
5 GLY X 255
ALA X 256
ILE X 243
ILE X 450
ILE X 215
None
0.92A 2r5qD-2y9eX:
undetectable
2r5qD-2y9eX:
8.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3abi PUTATIVE
UNCHARACTERIZED
PROTEIN PH1688


(Pyrococcus
horikoshii)
PF03435
(Sacchrp_dh_NADP)
PF16653
(Sacchrp_dh_C)
5 GLY A 117
ALA A 116
ASP A 115
GLY A  67
ILE A 306
NAD  A1001 (-3.6A)
None
None
None
None
0.93A 2r5qD-3abiA:
undetectable
2r5qD-3abiA:
13.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3dbg PUTATIVE CYTOCHROME
P450


(Streptomyces
coelicolor)
PF00067
(p450)
5 GLY A 359
ALA A 360
ASP A 361
PRO A  24
ILE A 356
None
0.87A 2r5qD-3dbgA:
undetectable
2r5qD-3dbgA:
10.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3fbs OXIDOREDUCTASE

(Agrobacterium
fabrum)
PF07992
(Pyr_redox_2)
5 GLY A 284
ALA A  17
ILE A  66
GLY A  22
ILE A   7
None
0.90A 2r5qD-3fbsA:
undetectable
2r5qD-3fbsA:
16.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3fkj PUTATIVE
PHOSPHOSUGAR
ISOMERASES


(Salmonella
enterica)
PF01380
(SIS)
5 ALA A  99
ILE A  75
GLY A 102
ILE A 118
ILE A  15
None
0.93A 2r5qD-3fkjA:
undetectable
2r5qD-3fkjA:
13.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3fv3 SAPP1P-SECRETED
ASPARTIC PROTEASE 1


(Candida
parapsilosis)
PF00026
(Asp)
5 ASP A  32
GLY A  34
ASP A  37
ILE A  76
ILE A 117
None
0.84A 2r5qD-3fv3A:
7.6
2r5qD-3fv3A:
14.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gve YFKN PROTEIN

(Bacillus
subtilis)
PF00149
(Metallophos)
5 GLY A 121
ALA A 122
ASP A 123
ILE A  89
ILE A 126
None
0.80A 2r5qD-3gveA:
undetectable
2r5qD-3gveA:
15.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3i5g MYOSIN HEAVY CHAIN
ISOFORM A


(Doryteuthis
pealeii)
PF00063
(Myosin_head)
PF00612
(IQ)
PF02736
(Myosin_N)
5 ALA A 265
ASP A 266
GLY A 460
ILE A 459
ILE A 224
None
0.87A 2r5qD-3i5gA:
undetectable
2r5qD-3i5gA:
7.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3i5g MYOSIN HEAVY CHAIN
ISOFORM A


(Doryteuthis
pealeii)
PF00063
(Myosin_head)
PF00612
(IQ)
PF02736
(Myosin_N)
5 GLY A 264
ALA A 265
ASP A 266
GLY A 460
ILE A 459
None
0.79A 2r5qD-3i5gA:
undetectable
2r5qD-3i5gA:
7.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3k28 GLUTAMATE-1-SEMIALDE
HYDE 2,1-AMINOMUTASE
2


(Bacillus
anthracis)
PF00202
(Aminotran_3)
5 ALA A 125
ILE A 285
GLY A 281
ILE A 109
ILE A 238
None
None
None
CA  A 430 (-4.9A)
None
0.88A 2r5qD-3k28A:
undetectable
2r5qD-3k28A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3kf3 INVERTASE

(Schwanniomyces
occidentalis)
PF00251
(Glyco_hydro_32N)
PF08244
(Glyco_hydro_32C)
5 ASP A 287
GLY A 289
ASP A 291
ILE A 485
PRO A 355
None
None
None
None
NAG  A5001 ( 4.9A)
0.76A 2r5qD-3kf3A:
undetectable
2r5qD-3kf3A:
11.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mmp ELONGATION FACTOR TU
2, ELONGATION FACTOR
TS


(Escherichia
coli)
PF00009
(GTP_EFTU)
PF00889
(EF_TS)
PF03143
(GTP_EFTU_D3)
PF03144
(GTP_EFTU_D2)
5 GLY A  16
ALA A  17
ASP A  21
GLY A 126
ILE A 125
None
0.89A 2r5qD-3mmpA:
undetectable
2r5qD-3mmpA:
10.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ALA A  28
ASP A  29
ASP A  30
GLY A  48
PRO A  81
ILE A  84
None
1.05A 2r5qD-3mwsA:
19.6
2r5qD-3mwsA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
None
0.73A 2r5qD-3mwsA:
19.6
2r5qD-3mwsA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
None
0.54A 2r5qD-3mwsA:
19.6
2r5qD-3mwsA:
76.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3nns DNA BINDING RESPONSE
REGULATOR B


(Thermotoga
maritima)
PF00072
(Response_reg)
5 GLY A  93
ALA A  94
ASP A  95
ILE A  75
ILE A  61
None
0.86A 2r5qD-3nnsA:
undetectable
2r5qD-3nnsA:
23.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3os7 GALACTOSE
MUTAROTASE-LIKE
PROTEIN


(Clostridium
acetobutylicum)
PF01263
(Aldose_epim)
5 GLY A 182
ILE A 107
GLY A 109
ILE A 111
PRO A  68
None
0.94A 2r5qD-3os7A:
undetectable
2r5qD-3os7A:
12.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
017  A 201 (-2.6A)
017  A 201 (-3.4A)
017  A 201 (-3.5A)
017  A 201 (-3.5A)
017  A 201 (-4.2A)
None
017  A 201 (-4.0A)
017  A 201 (-3.3A)
0.48A 2r5qD-3t3cA:
18.3
2r5qD-3t3cA:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
PRO A  81
017  A 201 (-2.6A)
017  A 201 (-3.4A)
017  A 201 (-3.5A)
017  A 201 (-3.5A)
017  A 201 (-4.2A)
None
017  A 201 (-4.0A)
None
0.80A 2r5qD-3t3cA:
18.3
2r5qD-3t3cA:
74.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3t44 INDOLE-3-GLYCEROL
PHOSPHATE SYNTHASE


(Mycobacterium
tuberculosis)
PF00218
(IGPS)
5 GLY A 235
ALA A 236
ASP A 237
ILE A 217
ILE A 206
None
0.78A 2r5qD-3t44A:
undetectable
2r5qD-3t44A:
15.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ttp HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  50
PRO A  81
ILE A  84
017  A 201 (-2.6A)
017  A 201 (-3.6A)
017  A 201 (-3.4A)
017  A 201 (-3.3A)
017  A 201 (-4.6A)
017  A 201 (-3.3A)
017  A 201 (-4.1A)
017  A 201 (-4.7A)
0.64A 2r5qD-3ttpA:
19.7
2r5qD-3ttpA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ttp HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
017  A 201 (-2.6A)
017  A 201 (-3.6A)
017  A 201 (-3.4A)
017  A 201 (-3.3A)
017  A 201 (-3.0A)
017  A 201 (-3.3A)
017  A 201 (-4.1A)
017  A 201 (-4.7A)
0.52A 2r5qD-3ttpA:
19.7
2r5qD-3ttpA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3u7s POL POLYPROTEIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
PRO A  81
017  A 202 ( 2.5A)
017  A 201 ( 3.5A)
017  A 201 (-3.4A)
017  A 201 (-3.2A)
017  A 201 ( 4.0A)
017  A 202 (-3.6A)
017  A 202 (-2.9A)
017  A 201 ( 3.5A)
017  A 202 (-4.0A)
0.59A 2r5qD-3u7sA:
20.1
2r5qD-3u7sA:
75.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3u95 GLYCOSIDE HYDROLASE,
FAMILY 4


(Thermotoga
neapolitana)
PF02056
(Glyco_hydro_4)
PF11975
(Glyco_hydro_4C)
5 GLY A  76
ALA A  77
ASP A  78
ILE A   3
ILE A  80
None
0.93A 2r5qD-3u95A:
undetectable
2r5qD-3u95A:
12.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ugk SACCHAROPINE
DEHYDROGENASE [NAD+,
L-LYSINE-FORMING]


(Saccharomyces
cerevisiae)
PF05222
(AlaDh_PNT_N)
5 GLY A 140
ALA A 209
GLY A 147
ILE A 316
ILE A 198
None
0.93A 2r5qD-3ugkA:
undetectable
2r5qD-3ugkA:
15.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3uhl PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
None
0.49A 2r5qD-3uhlA:
16.0
2r5qD-3uhlA:
76.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4aa9 CHYMOSIN

(Camelus
dromedarius)
PF00026
(Asp)
5 ASP A  34
GLY A  36
ASP A  39
ILE A  75
ILE A 122
None
None
None
SO4  A1332 (-4.4A)
None
0.76A 2r5qD-4aa9A:
8.4
2r5qD-4aa9A:
19.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4aip FE-REGULATED PROTEIN
B


(Neisseria
meningitidis)
PF00593
(TonB_dep_Rec)
PF07715
(Plug)
5 GLY A 165
ALA A 166
ASP A 118
GLY A 159
ILE A 168
None
0.92A 2r5qD-4aipA:
undetectable
2r5qD-4aipA:
9.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4cw5 DFNA

(Bacillus
velezensis)
PF03060
(NMO)
5 GLY A 559
GLY A 732
ILE A 731
PRO A 542
ILE A 539
FMN  A1753 (-3.0A)
None
None
None
None
0.93A 2r5qD-4cw5A:
undetectable
2r5qD-4cw5A:
12.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4db1 MYOSIN-7

(Homo sapiens)
PF00063
(Myosin_head)
PF02736
(Myosin_N)
5 ALA A 261
ASP A 262
GLY A 458
ILE A 457
ILE A 220
None
0.90A 2r5qD-4db1A:
undetectable
2r5qD-4db1A:
8.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4eqv INVERTASE 2

(Saccharomyces
cerevisiae)
PF00251
(Glyco_hydro_32N)
PF08244
(Glyco_hydro_32C)
5 ASP A 261
GLY A 263
ASP A 265
ILE A 464
PRO A 333
None
0.84A 2r5qD-4eqvA:
undetectable
2r5qD-4eqvA:
9.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ilk STARVATION SENSING
PROTEIN RSPB


(Escherichia
coli)
PF00107
(ADH_zinc_N)
PF08240
(ADH_N)
5 GLY A 206
ALA A 207
ASP A 208
ILE A 190
ILE A 176
None
0.80A 2r5qD-4ilkA:
undetectable
2r5qD-4ilkA:
17.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4iqy O-ACETYL-ADP-RIBOSE
DEACETYLASE MACROD2


(Homo sapiens)
PF01661
(Macro)
5 GLY A 191
ALA A 149
GLY A 146
ILE A 185
ILE A 153
None
0.93A 2r5qD-4iqyA:
undetectable
2r5qD-4iqyA:
18.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4iv9 TRYPTOPHAN
2-MONOOXYGENASE


(Pseudomonas
savastanoi)
PF01593
(Amino_oxidase)
5 GLY A  95
ALA A  96
ILE A  48
GLY A  75
ILE A 274
FAD  A 601 (-3.9A)
FAD  A 601 (-3.4A)
None
None
None
0.93A 2r5qD-4iv9A:
undetectable
2r5qD-4iv9A:
11.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4jga 3-OXOACYL-[ACYL-CARR
IER-PROTEIN]
SYNTHASE 2


(Rickettsia
rickettsii)
PF00109
(ketoacyl-synt)
PF02801
(Ketoacyl-synt_C)
5 GLY A 276
ALA A 301
ASP A 304
ILE A 273
ILE A 184
None
0.93A 2r5qD-4jgaA:
undetectable
2r5qD-4jgaA:
12.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4jyj ENOYL-COA
HYDRATASE/ISOMERASE


(Novosphingobium
aromaticivorans)
PF00378
(ECH_1)
5 ALA A 120
ASP A 121
ILE A 102
GLY A  54
ILE A  19
None
0.78A 2r5qD-4jyjA:
undetectable
2r5qD-4jyjA:
16.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4kpn NUCLEOSIDE
N-RIBOHYDROLASE 1


(Physcomitrella
patens)
PF01156
(IU_nuc_hydro)
5 GLY A  27
ASP A  29
GLY A 142
ILE A  51
ILE A  34
None
CA  A 400 ( 4.5A)
CA  A 400 ( 4.4A)
None
None
0.95A 2r5qD-4kpnA:
undetectable
2r5qD-4kpnA:
15.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4kpo NUCLEOSIDE
N-RIBOHYDROLASE 3


(Zea mays)
PF01156
(IU_nuc_hydro)
5 GLY A  10
ASP A  12
GLY A 124
ILE A  34
ILE A  17
None
CA  A 401 ( 4.8A)
CA  A 401 ( 4.3A)
None
None
0.89A 2r5qD-4kpoA:
undetectable
2r5qD-4kpoA:
16.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ALA A  28
ASP A  29
ASP A  30
GLY A  48
PRO A  81
ILE A  84
RIT  A 500 (-3.6A)
RIT  A 500 (-3.2A)
RIT  A 500 (-4.8A)
RIT  A 500 (-4.8A)
RIT  A 500 (-3.9A)
RIT  A 500 (-4.3A)
0.92A 2r5qD-4njvA:
20.2
2r5qD-4njvA:
82.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
RIT  A 500 (-2.4A)
RIT  A 500 (-3.9A)
RIT  A 500 (-3.6A)
RIT  A 500 (-3.2A)
RIT  A 500 (-4.8A)
RIT  A 500 (-3.9A)
RIT  A 500 (-4.3A)
0.63A 2r5qD-4njvA:
20.2
2r5qD-4njvA:
82.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
RIT  A 500 (-2.4A)
RIT  A 500 (-3.9A)
RIT  A 500 (-3.6A)
RIT  A 500 (-3.2A)
RIT  A 500 ( 4.5A)
RIT  A 500 (-3.4A)
RIT  A 500 (-4.3A)
RIT  A 500 (-3.9A)
RIT  A 500 (-4.3A)
0.52A 2r5qD-4njvA:
20.2
2r5qD-4njvA:
82.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4o1e DIHYDROPTEROATE
SYNTHASE DHPS


(Desulfitobacterium
hafniense)
PF00809
(Pterin_bind)
5 ASP A 170
GLY A 172
ALA A 173
PRO A 131
ILE A 165
None
0.88A 2r5qD-4o1eA:
undetectable
2r5qD-4o1eA:
18.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ovd PEPTIDOGLYCAN
GLYCOSYLTRANSFERASE


(Atopobium
parvulum)
PF00905
(Transpeptidase)
PF03717
(PBP_dimer)
5 GLY A 393
ASP A 395
ILE A 270
GLY A 268
ILE A 429
None
0.90A 2r5qD-4ovdA:
undetectable
2r5qD-4ovdA:
11.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ra7 PEPTIDOGLYCAN
GLYCOSYLTRANSFERASE


(Atopobium
parvulum)
PF00905
(Transpeptidase)
5 GLY A 933
ALA A 934
ILE A 887
GLY A 907
ILE A 906
None
0.90A 2r5qD-4ra7A:
undetectable
2r5qD-4ra7A:
12.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ttp DEPHOSPHO-COA KINASE

(Legionella
pneumophila)
PF01121
(CoaE)
5 ALA A 175
ASP A 176
ASP A 177
GLY A  12
ILE A 118
None
0.91A 2r5qD-4ttpA:
undetectable
2r5qD-4ttpA:
18.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4xgt FRQ-INTERACTING RNA
HELICASE


(Neurospora
crassa)
PF00270
(DEAD)
PF00271
(Helicase_C)
PF08148
(DSHCT)
PF13234
(rRNA_proc-arch)
5 GLY A 365
ALA A 364
ASP A 594
ILE A 369
ILE A 391
None
0.93A 2r5qD-4xgtA:
undetectable
2r5qD-4xgtA:
7.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4y9w ASPARTIC ACID
ENDOPEPTIDASE SAPP2


(Candida
parapsilosis)
PF00026
(Asp)
5 ASP A  32
GLY A  34
ASP A  37
ILE A  75
ILE A 116
None
0.76A 2r5qD-4y9wA:
8.0
2r5qD-4y9wA:
16.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ydf HTLV-1 PROTEASE

(Primate
T-lymphotropic
virus 1)
PF00077
(RVP)
6 ASP A  32
GLY A  34
ALA A  35
ASP A  36
GLY A  58
ILE A 100
4B1  A 201 (-2.9A)
4B1  A 201 ( 4.6A)
4B1  A 201 (-3.6A)
4B1  A 201 (-4.4A)
4B1  A 201 (-3.4A)
4B1  A 201 (-4.8A)
0.53A 2r5qD-4ydfA:
13.0
2r5qD-4ydfA:
35.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4yzg PROTEIN PHOSPHATASE
2C 57


(Arabidopsis
thaliana)
PF00481
(PP2C)
5 ASP A 238
GLY A 160
GLY A 179
ILE A 178
ILE A 230
None
0.93A 2r5qD-4yzgA:
undetectable
2r5qD-4yzgA:
16.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5b18 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
None
0.84A 2r5qD-5b18A:
18.2
2r5qD-5b18A:
72.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5b18 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
None
0.64A 2r5qD-5b18A:
18.2
2r5qD-5b18A:
72.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5inf CARBOXYL TRANSFERASE

(Streptomyces
ambofaciens)
PF01039
(Carboxyl_trans)
5 GLY A 431
ALA A 432
ASP A 433
ILE A 410
ILE A 361
None
0.88A 2r5qD-5infA:
undetectable
2r5qD-5infA:
15.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5nfg PROCARDOSIN-B,PROCAR
DOSIN-B


(Cynara
cardunculus)
no annotation 5 ASP A  80
GLY A  82
ASP A  85
ILE A 122
ILE A 169
None
0.82A 2r5qD-5nfgA:
7.1
2r5qD-5nfgA:
13.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5o1m RUBBER OXYGENASE

(Streptomyces
sp. K30)
PF09995
(DUF2236)
5 GLY A 158
ALA A 159
ASP A 160
ASP A 163
ILE A 396
HEM  A 600 (-3.5A)
HEM  A 600 (-3.5A)
None
None
None
0.91A 2r5qD-5o1mA:
undetectable
2r5qD-5o1mA:
13.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ovl 3-OXOACYL-[ACYL-CARR
IER-PROTEIN]
REDUCTASE FABG


(Mycolicibacterium
smegmatis)
no annotation 5 GLY A 123
ALA A 124
ILE A 146
GLY A  98
ILE A  99
None
None
NAP  A1001 (-4.6A)
NAP  A1001 (-3.4A)
NAP  A1001 (-4.5A)
0.94A 2r5qD-5ovlA:
undetectable
2r5qD-5ovlA:
17.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5t2z PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
None
0.60A 2r5qD-5t2zA:
19.4
2r5qD-5t2zA:
75.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5tgf UNCHARACTERIZED
PROTEIN


(Bacteroides
dorei)
PF00144
(Beta-lactamase)
5 GLY A  69
ALA A  70
ASP A  73
GLY A 221
ILE A 217
None
0.94A 2r5qD-5tgfA:
undetectable
2r5qD-5tgfA:
15.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6fiv RETROPEPSIN

(Feline
immunodeficiency
virus)
PF00077
(RVP)
5 ASP A  30
GLY A  32
ALA A  33
ASP A  34
GLY A  58
3TL  A 201 (-3.5A)
3TL  A 201 (-3.4A)
3TL  A 201 (-4.0A)
3TL  A 201 (-3.9A)
3TL  A 201 (-3.4A)
0.28A 2r5qD-6fivA:
15.7
2r5qD-6fivA:
31.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6fsa -

(-)
no annotation 5 ALA A 261
ASP A 262
GLY A 458
ILE A 457
ILE A 220
None
0.94A 2r5qD-6fsaA:
undetectable
2r5qD-6fsaA:
undetectable
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
0.81A 2r5qD-6upjA:
17.9
2r5qD-6upjA:
50.51